About
Vaderis is a biotechnology company developing targeted therapies for Hereditary Hemorrhagic Telangiectasia (HHT) and other rare vascular diseases that currently lack approved treatments.
Explore Vaderis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.